PMN‐MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis

Documenti analoghi

• Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium
  di: Zexuan Lian, et al.
  Pubblicazione: (2024)
• Targeting PMN‐MDSCs via CD300ld receptor for cancer immunotherapy
  di: Yuwei Li, et al.
  Pubblicazione: (2024)
• $\mathcal{B}^{3}$-Net: Controlled Posterior Bridge Learning for Multi-Task Dense Prediction
  di: Zhou, Meihua, et al.
  Pubblicazione: (2026)
• Impacts of A‐Site Dopants on the Local Structures and Macroscopic Properties of PMN Relaxor Ferroelectrics
  di: Xinya Feng, et al.
  Pubblicazione: (2025)
• Design and Development of an Electronic Platform for Allergen Immunotherapy in China
  di: Wanjun Wang, et al.
  Pubblicazione: (2025)